Dallah in talks to purchase entire shareholder share of Mohammed Alfagih & Partners capital

Dallah Healthcare Company (the company) announced on Monday its Board resolution on 18/09/2022 starting the negotiation of the purchase of with selling shareholders at Dr. Mohammed Rashed Alfagih Company & Partners (selling shareholders) to purchase their whole shares in Dr. Mohammed Rashed Alfagih Company & Partners which is equal to (34,395,349) normal share which represent (68.79%) of Dr. Mohammed Rashed Alfagih Company & Partners capital (proposed deal).

The company owns (15,604,651) normal share which represents (31.21%) of Dr. Mohammed Rashed Alfagih Company & Partners capital.

It is difficult to determine the financial effect of the proposed deal.

New updates in regards to the proposed deal will be announced in time.